Gerard Muñoz

EDUCATION / TRAINING:

• Acredited lecturer (AQU) since 2021
• Acredited researcher (AQU) since 2022
• PhD in Universitat Autonoma de Barcelona 2017.
• Master of Science in Respiratory Medicine in Universitat de Barcelona 2010-2011
• Post-degree in Thorax physiotherapy in Universitat Gimbernat, Barcelona 2009-2010.
• University Degree: Universitat de Blanquerna 2000-2003. 

ACADEMIC POSITIONS

• Associate Lecturer in Respiratory Physiotherapy. Universitat de Girona. From September 2008.
• Head of Department Degree in Physiotherapy UB-UdG From December 2020

PROFESSIONAL POSITIONS

• Respiratory Physiotherapist and Researcher, Girona Biomedical Research Institute. Pneumology department in Dr Trueta University Hospital.

RESEARCH LINES

• Bronchiectasis & Cystic Fibrosis
• Airway clearance techniques
• Pulmonary rehabilitation 

PUBLICATIONS (Last ten years)

• Herrero-Cortina B, Lee AL, Oliveira A, O’Neill B, Jácome C, Dal Corso S, Poncin W, Muñoz G, Inal-Ince D, Alcaraz-Serrano V, Reychler G, Bellofiore A, Posthumus A; Patient representative; Tonia T, Chalmers JD, Spinou A. European Respiratory Society statement on airway clearance techniques in adults with bronchiectasis. Eur Respir J. 2023;62(1):2202053. doi: 10.1183/13993003.02053-2022.
• Herrero-Cortina B, Spinou A, Oliveira A, O’Neill B, Jácome C, Dal Corso S, Poncin W, Muñoz G, Inal-Ince D, Alcaraz-Serrano V, Reychler G, Bellofiore A, Posthumus A; Patient representative; Chalmers JD, Lee AL. Airway clearance techniques and exercise in people with bronchiectasis: two different coins. Eur Respir J. 2023 Oct 12;62(4):2300741. doi: 10.1183/13993003.00741-2023. PMID: 37827549.
• Cazorla-González J, García-Retortillo S, Gacto-Sánchez M, Muñoz-Castro G, Serrano-Ferrer J, Román-Viñas B, López-Bermejo A, Font-Lladó R, Prats-Puig A. Effects of Crawling before Walking: Network Interactions and Longitudinal Associations in 7-Year-Old Children. Int J Environ Res Public Health. 2022 May 3;19(9):5561. doi: 10.3390/ijerph19095561. PMID: 35564955; PMCID: PMC9100207.
• Muñoz Castro G, Balañá Corberó A. Airway Clearance and Mucoactive Therapies. Semin Respir Crit Care Med. 2021 Aug;42(4):616-622. doi: 10.1055/s-0041-1730922. Epub 2021 Jul 14. PMID: 34261185.
• Muñoz G, de Gracia J, Giron R, Olveira C, Alvarez A, Buxó M, Birring SS, Vendrell M. Validation of a Spanish version of the Leicester Cough Questionnaire in cystic fibrosis. Chron Respir Dis. 2021 Jan-Dec;18:14799731211036903. doi: 10.1177/14799731211036903. PMID: 34730449;
• Rodrigues A, Muñoz G, Jácome C, Langer D, MP Selina and Burtin C. Current developments and future directions in respiratory physiotherapy. Eur Respir Rev 2020; 29: 200264 [https://doi.org/10.1183/ 16000617.0264-2020].
• Polverino E, Rosales-Mayor E, Benegas M, Menendez R, Alcaraz-Serrano V, Ansotegui E, Montull B, Girón RM, Cisneros C, Vendrell M, Muñoz G, Marcos MA, Sanchez M, Torres A. Pneumonic and non-pneumonic exacerbations in bronchiectasis: Clinical and microbiological differences. J Infect. 2018;77(2):99-106. doi: 10.1016/j.jinf.2018.04.006.
• Muñoz G, de Gracia J, Buxó M, Alvarez A, Vendrell M. Long-term benefits of airway clearance in bronchiectasis: a randomized placebo-controlled trial. Eur Respir J 2018. 11;51(1).
• Muñoz G, Buxó M, de Gracia J, Olveira C, Martinez-Garcia MA, Giron R, Polverino E, Alvarez A, Birring S, Vendrell M. Validation of a Spanish versión of the Leicester cough questionnaire in Non-cystic fibrosis bronchiectasis. Chron Respir Dis. 2016 May;13(2):128-36. doi: 10.1177/1479972316632005
• Vendrell M, Muñoz G, de Gracia J. Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis. The Open Respiratory Medicine Journal 2015;9:30-36
• Olveira C, Olveira G, Espildora F, Giron R, Muñoz G, Quittner A, Martinez-Garcia MA. Validation of a patient-reported outcome measure for bronchiectasis: Psychometric analyses of the Spanish QOLB-V3.0. Qual Life Res. 2014;23:1279-92.
• Vendrell M, Muñoz G, Sabater G. El futuro de la antibioterapia inhalada. Nuevos productos.Arch Bronconeumol. Arch Bronconeumol. 2011;47(Supl 6):30-32

RESEARCH  GRANTS AND COLLABORATION

Research Collaboration

• “Estudio Aztreonam: A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Evaluating Repeated Courses of Aztreonam for Inhalation Solution/Aztreonam 75 mg Powder and Solvent for Nebuliser Solution in Subjects with non-CF Bronchiectasis and Gram-Negative Endobronchial Infection (AIR-BX2).” Predoc Fellow.
• “Estudio calidad de vida: Prevalencia e impacto de los síntomas de depresión y ansiedad en la calidad de vida de pacientes con bronquiectasias no Fibrosis Quística (FQ).” Investigator
• “Estudio ejercicio: Elaboración de las ecuaciones de referencia para las pruebas de marcha de 6 minutos y de lanzadera (shuttle test) en población española adulta.” Investigator
• “Estudio EXAPOC: Impacto del número y gravedad de las exacerbaciones en el curso clínico de la EPOC.” Predoc Fellow.
• “Estudio Orbit 3: Estudio multicéntrico, aleatorizado, doble ciego, controlado con placebo para evaluar la seguridad y la eficacia de Pulmaquin® en el tratamiento de infecciones pulmonares crónicas por Pseudomonas aeruginosa en sujetos con bronquiectasia no debida a fibrosis quística, incluida la extensión abierta de 28 días y el subestudio farmacocinético (Orbit 3).” Investigator
• “Estudio agudizaciones: “Epidemiología y caracterización clínica-microbiológica de las agudizaciones en las Bronquiectasias no asociadas a fibrosis quística”. Investigator
• “Estudio EMBARC: “El registro europeo de bronquiectasias”.” Investigator
• “Estudio INSMED: “A Phase 2, Double-Blind, Placebo-Controlled, Three Parallel Groups Study to Determine the Efficacy, Safety and Tolerability, and Pharmacokinetics of INS1007 Once Daily in Subjects with Non-Cystic Fibrosis Bronchiectasis” Investigator

« He actively participates as a speaker/moderator in different national and international respiratory specialty conferences since 2011 »